Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Engineered Exosomes" report has been added to ResearchAndMarkets.com's offering. In the Engineered Exosome drug deals ...

In this article, we are going to take a look at where Mesoblast Limited (NASDAQ:MESO) stands against other best Australian stocks to buy according to billionaires. In December 2024, Ausbil ...

NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that pricing ...

Products are independently selected by our editors. We may earn an affiliate commission from links. True skin-care enthusiasts will tell you that the secret to achieving smooth, even-toned, dewy ...

Adia Labs introduced AdiaVita, a high-potency stem cell product containing 100 million cells and 3 trillion exosomes per dose, designed for clinical research and therapeutic use. A future product ...

The concentrations of colonic pro-inflammatory cytokines and chemokines were determined with a V-PLEX Custom Mouse Biomarkers with Proinflammatory Panel 1 and Cytokine Panel 1 purchased from Meso ...

CD93 is a transmembrane receptor that is mainly expressed on endothelial cells. A recent study found that upregulated CD93 in tumor vessels is essential for tumor angiogenesis in several cancers.